Edgewise Therapeutics Executives Sell Shares in Recent Transactions
Executives at Edgewise Therapeutics have engaged in regular stock trading activities, with the Chief Scientific Officer selling $25,539 worth of EWTX stock and the Chief Financial Officer selling $19,000 in shares. These transactions reflect standard financial practices within the company.
Why World Pulse Now?
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Stories
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Multi-Language
Switch languages to read your way
Save for Later
Your stories, stored for later
Live Stats
3,958
181
191
an hour ago
Mobile App
Available on iOS & AndroidThe mobile app adds more ways to stay informed — including offline reading, voice-enabled summaries, and personalized trend alerts.
1-Minute Daily Briefing
Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more
Why World Pulse Now?
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Stories
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Multi-Language
Switch languages to read your way
Save for Later
Your stories, stored for later
Live Stats
3,958
181
191
an hour ago
Mobile App
Available on iOS & AndroidThe mobile app adds more ways to stay informed — including offline reading, voice-enabled summaries, and personalized trend alerts.
1-Minute Daily Briefing
Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more